Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrinogen in congenital fibrinogen deficiency/reduction
CTR20220621Phase 3Completed
- Sponsor
- Nanyue Biopharmaceutical
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, sponsored by Nanyue Biopharmaceutical. Started Mar 2022; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiency
Beyond the preview
Go deeper on CTR20220621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220621.